NCT00740181 2022-01-14Decitabine, Cytarabine, GCSF for Refractory AML/MDSBrown UniversityPhase 2 Terminated9 enrolled 7 charts
NCT00186875 2017-07-28Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic LeukemiaSt. Jude Children's Research HospitalPhase 2 Completed47 enrolled 10 charts
NCT00066417 2013-05-01Peripheral Stem Cell Transplant in Treating Patients With High-Risk LeukemiaNational Cancer Institute (NCI)Phase 2 Terminated51 enrolled
NCT00003131 2012-08-22CMA-676 in Treating Patients With Acute Myeloid Leukemia in First RelapsePfizerPhase 2 Completed55 enrolled
NCT00003673 2012-08-22CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First RelapsePfizerPhase 2 Completed55 enrolled